共 182 条
[1]
Goldhirsch A(2015)Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Ann Oncol. 12 296-301
[2]
Winer EP(2013)Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol. 22 2013-301
[3]
Coates AS(2015)Ki67—no evidence for its use in node-positive breast cancer Nat Rev Clin Oncol. 12 296-20
[4]
Gelber RD(2005)Proliferation marker Ki-67 in early breast cancer J Clin Oncol 23 7212-83
[5]
Piccart-Gebhart M(2010)Ki67 in breast cancer: prognostic and predictive potential Lancet Oncol 11 174-13
[6]
Thürlimann B(2007)Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients Br J Cancer 96 1504-34
[7]
Senkus E(2008)Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients Breast 17 323-64
[8]
Kyriakides S(2011)Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer Working Group J Natl Cancer Inst 103 1656-906
[9]
Penault-Llorca F(2013)An International Ki67 Reproducibility Study J Natl Cancer Inst 105 1897-43
[10]
Poortmans P(2013)Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 Ring Study Cancer Sci 104 1539-44